| Website | polyactiva.com |
| Category | BioTech |
| Phone | +61 3 9657 0700 |
| info@polyactiva.com | |
| Employees |
| TOTAL | $9.53M |
| FUNDING TOTAL | $9.53M |
| Series B, 2/13 Medical Research Commercialisation Fund (MRCF) Brandon Biosciences Fund 1 (BBF1) Yuuwa Capital | $9.53M |
PolyActiva, a Melbourne, Australia-based biotechnology company. Founded in 2011 and led by Dr Russell Tait, CEO, PolyActiva has developed proprietary drug-polymer conjugate technology that enables site-specific drug delivery from medical device components such as ocular implants, intra-articular gel implants, and drug-eluting fibers.
